G. Franchini

HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques
20250 citationsauthor #25
High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaques
20251 citationsauthor #22
HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment
20252 citationsauthor #12
Development and optimization of human T-cell leukemia virus-specific antibody-dependent cell-mediated cytotoxicity (ADCC) assay directed to the envelope protein
20250 citationsauthor #12
BCG immunization mitigates SARS-CoV-2 replication in macaques via monocyte efferocytosis and neutrophil recruitment in lungs
20251 citationsauthor #14
HIV vaccine candidate efficacy mediated by epigenetic changes in CD14+ cells, cAMP-dependent efferocytosis and immunoinhibitory DC-10
20240 citationsauthor #12
Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition
20249 citationsauthor #5
Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells
20244 citationsauthor #12
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response
20243 citationsauthor #29
Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein
202311 citationsauthor #7
Publisher Correction: Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques
20230 citationsauthor #21
Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques
202310 citationsauthor #21
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells
20231 citationsauthor #24
HTLV-1 p12 modulates the levels of prion protein (PrPC) in CD4+ T cells
20231 citationsauthor #8
HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC
202319 citationsauthor #35
Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIVmac251 Acquisition
20236 citationsauthor #22
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
20232 citationsauthor #17
Implementation of the web‐based calculator estimating odds ratio of severe COVID‐19 for unvaccinated individuals in a country with high coronavirus‐related death toll
20223 citationsauthor #50
Implementation of the User-Friendly Odds Ratio Calculator for Unvaccinated Individuals in a Country with a High COVID-19 Death Toll
20220 citationsauthor #51
NK cells and monocytes modulate primary HTLV-1 infection
202218 citationsauthor #22
Hijacking Host Immunity by the Human T-Cell Leukemia Virus Type-1: Implications for Therapeutic and Preventive Vaccines
20228 citationsauthor #2
Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide
20228 citationsauthor #12
Decision letter: Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1
20210 citationsauthor #1
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
202121 citationsauthor #11
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
202115 citationsauthor #14
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
20210 citationsauthor #14
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition
202019 citationsauthor #32
Expression of CD40L by the ALVAC-SIV vector abrogates T cell responses in 1 macaques 2
20200 citationsauthor #25
A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques
202010 citationsauthor #23
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
202021 citationsauthor #58
Towards an improved AIDS vaccine: Enhancing the MHC Class I and II Antigen presentation of SIV proteins using ubiquitin and HLA-Dm targeting sequences
20200 citationsauthor #3
Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques
20207 citationsauthor #24
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection.
202019 citationsauthor #13
Functional properties and sequence variation of HTLV-1 p13
20208 citationsauthor #10
Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice
201916 citationsauthor #20
Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate
201918 citationsauthor #14
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
201919 citationsauthor #27
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response
201933 citationsauthor #20
p30 protein: a critical regulator of HTLV-1 viral latency and host immunity
201917 citationsauthor #9
A-102 Do biological differences exist between HTLV-1A and HTLV-1C?
20190 citationsauthor #6
Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence
201920 citationsauthor #7
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
20190 citationsauthor #28
Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine
201871 citationsauthor #8
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7
20189 citationsauthor #29
Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine
20180 citationsauthor #8
Neutrophil Vaccination Dynamics and Their Capacity To Mediate B Cell Help in Rhesus Macaques
201825 citationsauthor #8
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition
201867 citationsauthor #33
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
201824 citationsauthor #29
Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques
201815 citationsauthor #10
Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells
201830 citationsauthor #9
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection
201833 citationsauthor #13
T Cell Subsets in the Germinal Center: Lessons from the Macaque Model
201830 citationsauthor #2
Modulation of DNA/ALVAC/gp120 vaccine immune-response by vaccination with Insulin-Like Growth Factor 1 (IGF-1)
20170 citationsauthor #13
P-C11 Adjuvant-dependent innate and adaptive immunesignatures of risk of SIVmac251 acquisition
20170 citationsauthor #1
Vaccine-induced temporal cross-talk between myeloid cells reduces the risk of SIVmac251 acquisition
20170 citationsauthor #18
P-B7 Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
20160 citationsauthor #19
Material for Adjuvant dependent innate and adaptive immune signatures of risk of SIVmac 251 acquisition
20160 citationsauthor #50
Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.
201617 citationsauthor #11
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition
201634 citationsauthor #27
G-111 DNA prime/subunit boost using SIVE660 based rhFLSC yields 75% efficacy against cross clade SIVmac251 intrarectal challenge:
20160 citationsauthor #15
Correction: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
20160 citationsauthor #53
Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251
20167 citationsauthor #5
Molecular cloning of a unique humz
20160 citationsauthor #2
F-107 Adjuvant dependant RAS activation and mucosal envelope antibody to V2 correlate with reduced risk of Sivmac251 acquisition
20160 citationsauthor #1
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
2016210 citationsauthor #53
Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.
201513 citationsauthor #8
ORFI genetic polymorphisms in geographically distinct HTLV-1 infections
20150 citationsauthor #10
Human/Simian Immunodeficiency Virus Transmission and Infection at Mucosal Sites
20150 citationsauthor #2
HTLV-1 burden dependent on hijacking monocytes chemotaxis
20151 citationsauthor #11
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms
20150 citationsauthor #6
Role of myosin Va on HTLV-1 p8I protein's traffic to cell surface
20150 citationsauthor #6
Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques.
20158 citationsauthor #5
The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes
20150 citationsauthor #4
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms
20152 citationsauthor #6
Expression of alternatively spliced HTLV-1 mRNAs is influenced by mitosis and by a novel cis-acting regulatory sequence
20150 citationsauthor #6
ORFI genetic polymorphisms in geographically distinct HTLV-1 infections
20150 citationsauthor #10
The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes
20150 citationsauthor #4
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge
201555 citationsauthor #16
Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans
201552 citationsauthor #13
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms
20150 citationsauthor #6
Detection of HTLV-1 replication and CD4+ proliferation in the humanized BLT mouse model
20153 citationsauthor #10
Microscale purification of antigen-specific antibodies.
201523 citationsauthor #9
HTLV-1 burden dependent on hijacking monocytes chemotaxis
20150 citationsauthor #11
Role of myosin Va on HTLV-1 p8I protein's traffic to cell surface
20151 citationsauthor #6
Expression of alternatively spliced HTLV-1 mRNAs is influenced by mitosis and by a novel cis-acting regulatory sequence
20150 citationsauthor #6
Glucocorticoid Treatment at Moderate Doses of SIVmac251-Infected Rhesus Macaques Decreases the Frequency of Circulating CD14+CD16++ Monocytes But Does Not Alter the Tissue Virus Reservoir
201518 citationsauthor #21
Expression of Alternatively Spliced Human T-Cell Leukemia Virus Type 1 mRNAs Is Influenced by Mitosis and by a Novel cis-Acting Regulatory Sequence
201511 citationsauthor #8
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120
201536 citationsauthor #13
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms
20152 citationsauthor #6
Detection of HTLV-1 replication and CD4+ proliferation in the humanized BLT mouse model
20150 citationsauthor #10
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
2015124 citationsauthor #17
The contribution of monocytes/macrophages to HTLV-1 infection and persistence
20144 citationsauthor #6
Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251
20140 citationsauthor #17
G-104 Vaccine-induced myeloid cell population dampens protective immunity to SIV
20140 citationsauthor #15
A systems biology approach revealed distinct host responses between ALVAC-SIV and NYVAC-SIV vaccines during an evaluation of immunogenicity in rhesus macaques (VAC7P.992)
20140 citationsauthor #11
Transient Increase of Interferon-Stimulated Genes and No Clinical Benefit by Chloroquine Treatment During Acute Simian Immunodeficiency Virus Infection of Macaques
201416 citationsauthor #12
Modulation of RAS Pathways as a Biomarker of Protection against HIV and as a Means to Improve Vaccine Efficacy
20143 citationsauthor #50
Multiple Low-Dose Challenges in a Rhesus Macaque AIDS Vaccine Trial Result in an Evolving Host Response That Affects Protective Outcome
201412 citationsauthor #9
Evolving Host Response that affects Protective Outcome
20140 citationsauthor #9
Role of regulatory proteins in HIV-1/HTLV-1 coinfection
20140 citationsauthor #7

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT